Literature DB >> 16460278

Claudins and epithelial paracellular transport.

Christina M Van Itallie1, James M Anderson.   

Abstract

Tight junctions form continuous intercellular contacts controlling solute movement through the paracellular pathway across epithelia. Paracellular barriers vary among epithelia in electrical resistance and behave as if they are lined with pores that have charge and size selectivity. Recent evidence shows that claudins, a large family (at least 24 members) of intercellular adhesion molecules, form the seal and its variable pore-like properties. This evidence comes from the study of claudins expressed in cultured epithelial cell models, genetically altered mice, and human mutants. We review information on the structure, function, and transcriptional and posttranslational regulation of the claudin family as well as of their evolutionarily distant relatives called the PMP22/EMP/MP20/claudin, or pfam00822, superfamily.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460278     DOI: 10.1146/annurev.physiol.68.040104.131404

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  378 in total

1.  Albuterol modulates its own transepithelial flux via changes in paracellular permeability.

Authors:  Hoshang J Unwalla; Gabor Horvath; Felix D Roth; Gregory E Conner; Matthias Salathe
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

2.  SOS1 and Ras regulate epithelial tight junction formation in the human airway through EMP1.

Authors:  Joanne Durgan; Guangbo Tao; Matthew S Walters; Oliver Florey; Anja Schmidt; Vanessa Arbelaez; Neal Rosen; Ronald G Crystal; Alan Hall
Journal:  EMBO Rep       Date:  2014-11-13       Impact factor: 8.807

3.  Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide.

Authors:  Rishi B Patel; Sainath R Kotha; Lynn A Sauers; Smitha Malireddy; Travis O Gurney; Niladri N Gupta; Terry S Elton; Ulysses J Magalang; Clay B Marsh; Boyd E Haley; Narasimham L Parinandi
Journal:  Toxicol Mech Methods       Date:  2012-06       Impact factor: 2.987

Review 4.  Claudins and renal salt transport.

Authors:  Shigeaki Muto; Mikio Furuse; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

5.  Claudin-5 participates in the regulation of endothelial cell motility.

Authors:  Astrid Escudero-Esparza; Wen G Jiang; Tracey A Martin
Journal:  Mol Cell Biochem       Date:  2011-10-26       Impact factor: 3.396

6.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

7.  Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice.

Authors:  Lei Ding; Zhe Lu; Oded Foreman; Rodney Tatum; Qun Lu; Randall Renegar; Jian Cao; Yan-Hua Chen
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

Review 8.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 9.  Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.

Authors:  Jonathan D Black; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Womens Health (Lond)       Date:  2014-01

10.  Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis.

Authors:  Guanglei Li; Per Flodby; Jiao Luo; Hidenori Kage; Arnold Sipos; Danping Gao; Yanbin Ji; LaMonta L Beard; Crystal N Marconett; Lucas DeMaio; Yong Ho Kim; Kwang-Jin Kim; Ite A Laird-Offringa; Parviz Minoo; Janice M Liebler; Beiyun Zhou; Edward D Crandall; Zea Borok
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.